Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Free Cash Flow: 2016-2025

Historic Free Cash Flow for Organogenesis Holdings (ORGO) over the last 9 years, with Sep 2025 value amounting to $844,000.

  • Organogenesis Holdings' Free Cash Flow fell 86.22% to $844,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$51.7 million, marking a year-over-year decrease of 1427.81%. This contributed to the annual value of $4.2 million for FY2024, which is 36.27% down from last year.
  • Organogenesis Holdings' Free Cash Flow amounted to $844,000 in Q3 2025, which was up 102.31% from -$36.5 million recorded in Q2 2025.
  • Organogenesis Holdings' Free Cash Flow's 5-year high stood at $13.1 million during Q2 2021, with a 5-year trough of -$36.5 million in Q2 2025.
  • In the last 3 years, Organogenesis Holdings' Free Cash Flow had a median value of $1.1 million in 2023 and averaged -$4.4 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first spiked by 355.25% in 2023, then crashed by 1,377.50% in 2025.
  • Organogenesis Holdings' Free Cash Flow (Quarterly) stood at $12.7 million in 2021, then slumped by 122.45% to -$2.9 million in 2022, then soared by 355.25% to $7.3 million in 2023, then rose by 3.92% to $7.6 million in 2024, then plummeted by 86.22% to $844,000 in 2025.
  • Its Free Cash Flow stands at $844,000 for Q3 2025, versus -$36.5 million for Q2 2025 and -$23.6 million for Q1 2025.